Trials / Completed
CompletedNCT05878925
Nasal Olfactory Stimulation and Its Effect on Respiratory Drive in Preterm Infants
Nasal Olfactory Stimulation and Its Effect on Respiratory Drive in Preterm Infants - A Randomized Cross-over Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 72 Hours
- Healthy volunteers
- Not accepted
Summary
This trial analyzes the effect of an olfactory stimulation with vanilla or strawberry aroma compared to placebo on desaturations and bradycardia in preterm infants with apnea of prematurity. Infants on continuous positive airway pressure (CPAP) support will be included and the aroma will be applied to the inner surface of the CPAP mask using designated scent pens. The trial uses a cross-over design. Infants are randomised to begin the study with either aroma or placebo which will be applied into the breathing mask every 3 to 4 hours during 12 hours for each of the two intervention periods. Identically looking pens with either aroma or placebo are used and patients, parents, medical staff and the study team are blinded to this allocation. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aroma | The study intervention is an olfactory stimulation with vanilla or strawberry aroma. The aroma will be applied to the inner surface of the nCPAP mask of preterm infants using designated scent pens every 3-4 hours over a period of 12 hours. The two aromas will be applied in blocks of 5 consecutive infants (5 infants vanilla, 5 infants strawberry, and so forth). |
| OTHER | Placebo | During the control intervention, identically looking placebo pens will be used to apply a colored carrier solution (without aroma) to the inner surface of the nCPAP mask of preterm infants in the same manner. |
Timeline
- Start date
- 2023-06-14
- Primary completion
- 2025-01-24
- Completion
- 2025-01-24
- First posted
- 2023-05-30
- Last updated
- 2025-04-04
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05878925. Inclusion in this directory is not an endorsement.